Concepedia

Nikolay Pozdnyakov

NP

18

Publications

909

Citations

16

H-Index

1995

Active since

Affiliations

Pfizer (United States)(Current)

Smith-Kettlewell Eye Research Institute

Oakland University

Memorial Sloan Kettering Cancer Center

Cornell University

Nikolay Pozdnyakov is an author at Pfizer (United States) specializing in medicine, biochemistry, and natural sciences.

Top concepts

Publications per year

1995–2018

18

Publications

18

Concentration-Dependent Modulation of Amyloid-β in Vivo and in Vitro Using the γ-Secretase Inhibitor, LY-450139

Thomas A. Lanz, Michael J. Karmilowicz, Kathleen M. Wood et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 133 citations

γ-Secretase Modulator (GSM) Photoaffinity Probes Reveal Distinct Allosteric Binding Sites on Presenilin

Nikolay Pozdnyakov, Heather E. Murrey, Christina J. Crump et al. · Journal of Biological Chemistry · 2013 · 103 citations · Full text

, , +20

BMS-708,163 Targets Presenilin and Lacks Notch-Sparing Activity

Christina J. Crump, Suita V. Castro, Feng Wang et al. · Biochemistry · 2012 · 93 citations · Full text

, , +15

Passive immunotherapy targeting amyloid-β reduces cerebral amyloid angiopathy and improves vascular reactivity

Kelly R. Bales, Sharon O'Neill, Nikolay Pozdnyakov et al. · Brain · 2015 · 64 citations · Full text

, , +23

Piperidine Acetic Acid Based γ-Secretase Modulators Directly Bind to Presenilin-1

Christina J. Crump, Benjamin A. Fish, Suita V. Castro et al. · ACS Chemical Neuroscience · 2011 · 62 citations · Full text

, , +16

Rows per page

1–5 of 18